Mercer Global Advisors
TNXP icon

Mercer Global Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

Mercer Global Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
+23,818
New +$307K ﹤0.01% 2790

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mercer Global Advisors's TNXP Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 23,818 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #2790 among its holdings.

103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Mercer Global Advisors held 23,818 shares of Tonix Pharmaceuticals worth $304K as of Q2 2026.
  • Tonix Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2790 holding.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.